These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1638033)

  • 1. Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders.
    Mittelman M; Floru S; Djaldetti M
    Blood; 1992 Aug; 80(3):841-3. PubMed ID: 1638033
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin.
    Beresford CH
    N Z Med J; 1989 Apr; 102(866):185-6. PubMed ID: 2652007
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of once- versus thrice-weekly subcutaneous recombinant human erythropoietin in children receiving continuous cycling peritoneal dialysis.
    Ongkingco JR; Ruley EJ; Turner ME; Fragale MR
    Am J Nephrol; 1994; 14(1):14-8. PubMed ID: 8017476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum erythropoietin levels in patients with severe anemia secondary to inflammatory bowel disease and the use of recombinant human erythropoietin in patients with anemia refractory to treatment.
    Demirtürk L; Hülagü S; Yaylaci M; Altin M; Ozel M
    Dis Colon Rectum; 1995 Aug; 38(8):896-7. PubMed ID: 7634987
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficiency of once-weekly subcutaneous administration of recombinant human erythropoietin versus three times a week administration in hemodialysis patients.
    Lago M; Pérez-García R; García de Vinuesa MS; Anaya F; Valderrábano F
    Nephron; 1996; 72(4):723-4. PubMed ID: 8730458
    [No Abstract]   [Full Text] [Related]  

  • 6. Subcutaneous recombinant human erythropoietin treatment of children undergoing peritoneal dialysis.
    Fine RN
    Contrib Nephrol; 1991; 89():186-9. PubMed ID: 1893725
    [No Abstract]   [Full Text] [Related]  

  • 7. [A multicenter trial of Recormon within the framework of international controlled research].
    Tareeva IE; Nikolaev AIu; Klepikov PV; Lashutin SV; Riabov SI; Shostka GD; Ermolenko VM; Rozental' RL; Vorob'ev PA; Miagkov AV
    Ter Arkh; 1992; 64(8):59-62. PubMed ID: 1440400
    [No Abstract]   [Full Text] [Related]  

  • 8. Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial.
    Cazzola M; Ponchio L; Beguin Y; Rosti V; Bergamaschi G; Liberato NL; Fregoni V; Nalli G; Barosi G; Ascari E
    Blood; 1992 Jan; 79(1):29-37. PubMed ID: 1728318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human erythropoietin in patients on peritoneal dialysis.
    Bargman J
    Perit Dial Int; 1989; 9(4):245-6. PubMed ID: 2488375
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant human erythropoietin therapy in patients with rheumatoid arthritis with the anemia of chronic disease.
    Salvarani C; Lasagni D; Casali B; Macchioni P; Boiardi L; Rossi F; Rivasi P; Portioli I
    J Rheumatol; 1991 Aug; 18(8):1168-71. PubMed ID: 1941817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of subcutaneous low-dose erythropoietin in patients with chronic renal failure despite functional iron deficiency.
    Bedani PL; Cecchetti E; Gilli P
    Nephron; 1995; 71(4):459-60. PubMed ID: 8587628
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcutaneous versus intravenous recombinant human erythropoietin administration in hemodialysis patients.
    Boran M; Dalva I; Yazicioğlu A; Cetin S
    Nephron; 1993; 63(1):113-4. PubMed ID: 8446239
    [No Abstract]   [Full Text] [Related]  

  • 13. Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes.
    Ghio R; Balleari E; Ballestrero A; Gatti AM; Mareni C; Massa G; Patrone F; Sessarego M; Timitilli S
    Acta Haematol; 1993; 90(2):58-64. PubMed ID: 8285019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of erythropoietin in the treatment of patients with oncohematological diseases].
    Lysenko DA; Lutsenko OM
    Lik Sprava; 2005 Jun; (4):69-75. PubMed ID: 16158722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of withdrawing erythropoietin.
    Taylor JE; Henderson IS; Mactier RA; Stewart WK
    BMJ; 1991 Feb; 302(6771):272-3. PubMed ID: 1998794
    [No Abstract]   [Full Text] [Related]  

  • 16. Guidelines for the use of recombinant human erythropoietin.
    Barosi G; Cazzola M; De Vincentiis A; Grossi A; Tura S
    Haematologica; 1994; 79(6):526-33. PubMed ID: 7896210
    [No Abstract]   [Full Text] [Related]  

  • 17. rhEPO treatment of anemia in uremic patients.
    Bommer J; Barth HP; Schwöbel B
    Contrib Nephrol; 1990; 87():59-67. PubMed ID: 2093542
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of once weekly erythropoietin therapy in children on continuous ambulatory peritoneal dialysis.
    Hisano S; Kaku Y; Ueda K; Onoyama K
    Acta Paediatr Jpn; 1991 Aug; 33(4):450-4. PubMed ID: 1792903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of the anaemia of chronic renal failure with recombinant human erythropoietin.
    Winearls CG
    Drugs; 1989 Sep; 38(3):342-5. PubMed ID: 2806134
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant human erythropoietin for the treatment of anemia in chronic myelogenous leukemia.
    Bourantas KL; Tsiara S; Makis A; Chaidos A; Christou L; Konstantinidou P; Kolios G; Seferiadis K
    Eur J Haematol; 1997 Oct; 59(4):263-5. PubMed ID: 9338625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.